Stocks
Sandoz Group AGSDZNY
OTCHealthcareGeneric Pharmaceuticals$77.77-0.73%
A global manufacturer of generic medicines and biosimilars, the company supplies off‑patent treatments across areas such as oncology, immunology, and antibiotics. Spun off from Novartis in 2023, Sandoz operates one of the largest generics platforms in Europe and maintains a growing biosimilars pipel...
Market Cap: $33.7B52W Range: $35.61 – $94.15
Congressional Interest in Sandoz Group AG (SDZNY)
2 members of Congress have disclosed 2 trades in Sandoz Group AG (SDZNY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
0
Sells
2
Who in Congress Is Trading SDZNY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-24 | George Whitesides | sell | $1K – $15K |
| 2024-01-09 | John W Hickenlooper | sell | $1K – $15K |